“ We are a creative institution and should safeguard researchers in their work and in the development of their own ideas, but at the same time we… ”
In Conversation
“ The extended period for reimbursement negatively affects patient care, and strategies need to be devised to expedite this process without compromising the quality of decision-making ”
“ In Portugal, the challenge in mental health care is not necessarily a shortage of psychiatric doctors in terms of numbers but rather a distribution issue ”
“ There are around 550 bone marrow transplants done in the country annually, but we have a bottleneck in allogeneic transplants, and we are well behind where… ”
“ Reliance Life Sciences envisions a future characterized by a diverse and extensive portfolio. This involves not only a variety of product streams but also depth in… ”
“ The paradigm shift India needs is to transition from being the "pharmacy of the world" to actively engaging in pharmaceutical discoveries. This shift is the central… ”
“ In essence, the market access system has progressed in terms of consolidation, but there is a call for it to become more data-driven and collaborative in… ”
“ As a result [of the NCG's comprehensive negotiation process with pharma companies], we secured remarkable discounts ranging from 23 percent to an incredible 99 percent off… ”
“ My role encompasses not only overseeing the strategic growth of the Asian Cancer Institutes but also navigating the complex healthcare landscape in India. The journey involves… ”
“ While crucial, Ayushman Bharat is not a standalone solution. India’s strategy should involve a comprehensive approach, including an increase in the overall healthcare budget ”
Raghuveer Kini – Director General, Chemexcil (Basic Chemicals, Cosmetics & Dyes Export Promotion Council), India
“ In essence, the opportunity lies in aligning chemical production with eco-friendly practices, meeting the sustainability criteria set by major markets. This not only addresses current environmental… ”
“ The delicate equilibrium sought by the government, balancing healthcare accessibility, fostering innovation, and promoting value-driven pharmaceutical development, is evident ”